NCT00030654 Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE3
NCT00030602 Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00030290 Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate Status COMPLETED Phase PHASE1
NCT00030277 High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer Status COMPLETED Phase PHASE1
NCT00029224 Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions Status COMPLETED Phase PHASE4
NCT00028769 S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00028574 Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer Status COMPLETED Phase PHASE3
NCT00027859 Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE3
NCT00027794 Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer Status COMPLETED Phase PHASE2
NCT00027781 MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00027599 APC8015 and Bevacizumab in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00026754 Eligibility Screening for the NIH Intramural Research Program Clinical Protocols Status COMPLETED Phase N/A
NCT00026377 SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE1
NCT00025194 Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00025116 ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00024414 DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer Status UNKNOWN Phase PHASE2
NCT00024232 Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00024167 Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer Status TERMINATED Phase PHASE3
NCT00023829 Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer Status COMPLETED Phase PHASE3